Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Steris $1.6B Debt Financing with JPMorgan Chase Bank, N.A.
STERIS plc entered into a new $1.6 billion revolving credit agreement with JPMorgan Chase Bank and other lenders, replacing its existing 2024 facility. The new facility matures on November 4, 2031, and includes an accordion feature allowing for an incremental increase of up to $800 million. The proceeds will be used for general corporate purposes, including swingline borrowings and letters of credit.
Lycia Therapeutics 10% Owner Venrock Healthcare Capital Partners III L.P. Buys $224K of Stock
Venrock Healthcare Capital Partners III L.P., 10% Owner, bought 8,305 shares of Lycia Therapeutics, Inc. at $26.95 a share, worth $224K in total on Nov 2, 2026. Shares held after the trade: 6,858,542 (+0.1%).
CB Financial Services SEVP and COO Jennifer L. George Sells $84K of Stock
Jennifer L. George, SEVP and COO, sold 2,080 shares of CB Financial Services, Inc. at $40.39 to $40.41 a share (average $40.39) in 2 transactions, worth $84K in total on Nov 2, 2026. Shares held after the trade: 13,170 (-2.1%).
GRI Bio held its 2026 Annual Meeting of Stockholders where shareholders elected W. Marc Hertz and David Szekeres as Class III directors and ratified WithumSmith+Brown, PC as the independent auditor. Stockholders also approved an amendment to the 2018 Equity Incentive Plan, increasing the share reserve by 546,529 shares and extending the evergreen provision to 2036.
AGL Private Credit Income Fund reported its Q3 2026 financial results, generating $14.6 million in net investment income ($0.60 per share). The fund's net asset value (NAV) per share increased to $23.46 from $23.28 in the prior quarter, while the total portfolio fair value grew to $1.5 billion across 47 companies.
Figma, Inc. filed its Form 10-Q for the period ending October 30, 2026, reporting a multi-class share structure with 457.7 million Class A and 77.9 million Class B shares outstanding. The filing highlights significant risk factors related to rapid growth, AI competition, and the potential for third-party AI agents to circumvent existing pricing models.
Recursion Pharmaceuticals Insider Blake Borgeson Sells $155K of Stock
Blake Borgeson sold 40,000 shares of Recursion Pharmaceuticals, Inc. at $3.88 a share, worth $155K in total on Nov 3, 2026. Shares held after the trade: 6,068,287 (-0.7%).
Vir Biotechnology reported a significant increase in total revenues to $238.7 million for the nine months ended September 30, 2026, primarily driven by license and collaboration revenue. Despite this, the company recorded a net loss of $141.9 million for the same period, though this was a substantial improvement from the $395.1 million net loss in the prior year due to higher revenues and reduced research and development expenses.
FatPipe, Inc. reported its second quarter fiscal year 2027 financial results, achieving revenue of $4.83 million, a 22% increase year-over-year. The company swung to a net income of $1.2 million from a slight loss in the prior year period, driven by strong demand for its SD-WAN and cybersecurity solutions. Management highlighted a 24.1% Adjusted EBITDA margin and growth in recurring revenue as key performance drivers.
Term
Q2 2027
“We are pleased with our continued revenue growth and profitability this quarter, reflecting the strength of our business model and continued execution across the organization. We remain focused on expanding our channel partnerships, growing our customer base, and building on the momentum across our SD-WAN, cybersecurity, and network monitoring offerings.”
Dr. Ragula Bhaskar, CEO of FatPipe
“Our second quarter results reflect continued progress in growing our recurring revenue base. With revenue increasing 22% year-over-year and an Adjusted EBITDA margin of 24.1%, we continue to demonstrate our ability to deliver profitable growth while investing in strategic initiatives. We believe our financial position provides a strong foundation to expand our sales organization, strengthen our partner ecosystem, and pursue additional growth opportunities.”
Macerich is executing its 'Path Forward' plan, focusing on leasing 1,000 units and backfilling 30 anchors to drive $140 million in incremental NOI by 2028 while reducing leverage through $2 billion in dispositions.
For the nine months ended September 30, 2026, Nature's Sunshine Products reported net sales of $356.5 million, remaining flat compared to the prior year, while net income attributable to common shareholders decreased to $10.5 million from $15.4 million. The company maintained a strong balance sheet with $89.4 million in cash and cash equivalents despite facing significant foreign exchange losses during the period.
Life360 Insider John Philip Coghlan Sells $183K of Stock
John Philip Coghlan sold 4,000 shares of Life360, Inc. at $45.29 to $46.69 a share (average $45.80) in 3 transactions, worth $183K in total on Nov 2, 2026. Shares held after the trade: 8,431 (-7.9%).
Geron Corporation reported a net income of $1.35 million for the third quarter of 2026, a significant improvement from the $18.4 million net loss in the same period of 2025, driven by a 27% increase in product revenue to $60.1 million. Despite the quarterly profit, the company recorded a net loss of $19.0 million for the first nine months of 2026 as it continues to manage high operating expenses and inventory investments.
Seaport Entertainment Group Inc. reported total revenues of $79.7 million for the nine months ended September 30, 2026, a decrease from $100.9 million in the prior year period. The company's total assets decreased to $524.7 million from $650.1 million at year-end 2025, primarily due to the disposition of assets held for sale.
Chord Energy reported Q3 2026 financial results with oil volumes of 165.5 MBopd, exceeding the top-end of guidance. The company raised its full-year 2026 oil volume guidance and increased its Adjusted Free Cash Flow expectations by approximately $200 million since August. Additionally, Chord announced the divestiture of non-operated Marcellus assets for $550 million, with closing expected in Q4 2026.
Term
Q3 2026
“Chord’s operational momentum continues and the team delivered solid results in the third quarter. Third quarter volumes were above the top-end of guidance and Chord raised FY26 oil volume guidance for the second time this year. We continue to execute on our strategy and make further progress on key projects, including our 4-mile program and base production enhancement. Chord also executed several third-party marketing agreements that, alongside other initiatives implemented over the past two years, increased annual run-rate savings to $225 million. Chord continues to drive efficiency through every aspect of the business, which pu”
Michael Lou, Chord Energy’s President and Chief Executive Officer
INVO Fertility, Inc. implemented a 1-for-4 reverse stock split of its issued, outstanding, and authorized common stock effective October 30, 2026. The split reduced the number of outstanding shares to approximately 1.2 million and adjusted the authorized share count to 62.5 million to maintain compliance with Nasdaq listing requirements. Trading commenced on a split-adjusted basis under the existing symbol 'IVF' with a new CUSIP number.
Evommune Licensing Deal with Hinova Pharmaceuticals Inc. Worth $30M
Evommune has entered into an exclusive license agreement with Hinova Pharmaceuticals to develop and commercialize EVO570, a VAV1 molecular glue degrader, globally excluding Greater China. Evommune will pay $20 million upfront in cash and $10 million in pre-funded warrants, with Hinova eligible for up to $1.07 billion in additional milestone payments plus tiered royalties.
USA Compression Partners, LP reported its quarterly financial results for the period ended September 30, 2026, focusing on its natural gas compression services and contract operations. The filing includes detailed financial statements and management's discussion on operational efficiency and fleet utilization.
Novagold Resources M&A Deal with Paulson Advisers LLC
NOVAGOLD shareholders approved a transaction to consolidate 100% ownership of the Donlin Gold project by acquiring the 40% interest held by Paulson Advisers LLC. The all-share transaction involves the creation of a new Delaware parent company, New NOVAGOLD, which will acquire all outstanding NOVAGOLD shares and the Donlin Gold interests in exchange for new voting and non-voting stock.
Verisign Exec. Chairman, Pres, & CEO D. James Bidzos Sells $1.03M of Stock
D. James Bidzos, Exec. Chairman, Pres, & CEO, sold 3,300 shares of Verisign Inc at $307.84 to $316.40 a share (average $311.99) in 8 transactions, worth $1.03M in total on Nov 3, 2026. Shares held after the trade: 365,227 (-0.1%).
Pinnacle Financial Partners, Inc. is scheduled to participate in a fireside chat at the BancAnalysts Association of Boston Conference on November 5, 2026. The company furnished a formal investor presentation deck titled 'Scaling the Model' as an exhibit to the filing, which includes strategic updates following its recently completed business combination with Synovus Financial Corp.
Finward Bancorp's Board of Directors declared a quarterly cash dividend of $0.12 per share on its common stock. The dividend is payable on December 2, 2026, to shareholders of record as of November 18, 2026.
RYAM is pivoting to a high-margin Cellulose Specialties focus while managing a strategic review delay and significant economic headwinds from Canadian paperboard tariffs.
Ascent Industries Co. reported a return to profitability in Q3 2026 with net income of $1.4 million compared to a $2.1 million loss in the prior year period. While nine-month results show a significant decrease in net income from $1.9 million to $92 thousand due to the absence of discontinued operations income, the company successfully completed a $13.6 million acquisition and continued its share repurchase program.
Regions Financial Corporation filed a formal investor presentation deck to be used at various institutional investor meetings and events during November and December 2026. The materials outline the company's strategic priorities, including its focus on high-growth Southeast markets, asset/liability management, and disciplined expense management.
Dole Insider Pale Fire Capital SE Buys $12.9M of Stock
Pale Fire Capital SE bought 986,557 shares of Dole plc at $13.05 to $13.38 a share (average $13.10) in 3 transactions, worth $12.9M in total between Nov 2, 2026 and Nov 4, 2026. Shares held after the trade: 11,269,177 (+0.0%).
Summit Therapeutics reported a net loss of $613.5 million for the nine months ended September 30, 2026, compared to a net loss of $860.4 million in the prior year period. The company ended the quarter with $629.8 million in cash, cash equivalents, and short-term investments, while total stockholders' equity decreased to $564.7 million from $658.9 million at year-end 2025.
ZoomInfo Technologies Inc. filed its Form 10-Q for the period ended September 30, 2026, reporting 293,442,121 shares of common stock outstanding as of October 30, 2026. The filing highlights risks related to AI competition, macroeconomic impacts on customer spending, and the company's transition toward AI-enabled products and monetization strategies.
TON Strategy General Counsel/Corp Secretary Mary Marbach Sells $75.2K of Stock
Mary Marbach, General Counsel/Corp Secretary, sold 26,188 shares of TON Strategy Co at $2.87 a share, worth $75.2K in total on Nov 3, 2026. Shares held after the trade: 286,085 (-8.4%).
Viemed Healthcare reported a 20.7% increase in revenue for the nine months ended September 30, 2026, reaching $234.2 million compared to $194.1 million in the prior year. Net income attributable to the company grew to $10.0 million for the same period, while the company maintained a strong balance sheet with $150.1 million in total shareholders' equity.